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Abstract We investigated the expression of P2X5, P2X7,
P2Y1 and P2Y2 receptor subtypes in adult human anagen
hair follicles and in relation to markers of proliferation
[proliferating cell nuclear antigen (PCNA) and Ki-67],
keratinocyte differentiation (involucrin) and apoptosis
(anticaspase-3). Using immunohistochemistry, we showed
that P2X5, P2Y1 and P2Y2 receptors were expressed in
spatially distinct zones of the anagen hair follicle: P2Y1
receptors in the outer root sheath and bulb, P2X5 receptors
in the inner and outer root sheaths and medulla and P2Y2
receptors in living cells at the edge of the cortex/medulla.
P2X7 receptors were not expressed. Colocalisation experi-
ments suggested different functional roles for these recep-
tors: P2Y1 receptors were associated with bulb and outer
root sheath keratinocyte proliferation, P2X5 receptors were
associated with differentiation of cells of the medulla and
inner root sheaths and P2Y2 receptors were associated with
early differentiated cells in the cortex/medulla that contrib-
ute to the formation of the hair shaft. The therapeutic
potential of purinergic agonists and antagonists for control-
ling hair growth is discussed.







NGS normal goat serum
NHS normal horse serum
IRS inner root sheath
ORS outer root sheath
PBS phosphate buffered saline
PCNA proliferating cell nuclear antigen
Introduction
The cells of the lower portion of the hair follicle bulb are
undifferentiated matrix cells. These are rapidly dividing
cells that give rise to eight different cell lineages [1]. From
within outwards, these include the medulla, cortex and hair
cuticle cell lineages that make up the hair shaft; the inner
root sheath cuticle, Huxley’s and Henle’s layers that make
up the inner root sheath (IRS); and the companion layer and
the outer root sheath (ORS) [1]. The hair cycle is divided
into periods of hair growth (anagen), which are followed by
a regression phase (catagen), when the lower part of the
hair follicle undergoes programmed cell death [2], and a
resting phase (telogen), before onset of a new growth
phase.
The growing anagen hair follicle is an attractive system
for studying proliferation and differentiation. There is increas-
ing evidence that purinergic signalling can have long-term,
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trophic effects on these processes [3, 4]. Adenosine 5’-
triphosphate (ATP) is now recognised as an important
messenger molecule for cell–cell communication, with ATP
binding specifically to purinergic receptors [5, 6]. Purinergic
receptors are classified into two groups: P1 receptors are
selective for adenosine, and P2 receptors are selective for ATP
and adenosine 5’-diphosphate (ADP), which act as extracel-
lular signalling molecules [6]. P2 receptors are divided into
two main families: P2X receptors, which are ligand-gated
ion channels, and P2Y receptors, which are G protein-
coupled, based on molecular structure, transduction mecha-
nisms and pharmacological properties [7]. Seven subtypes of
P2X receptors [8] and eight subtypes of P2Y receptors are
recognised [9]. There is growing evidence that ATP may act
as an important local messenger in the epidermis. Purinergic
receptors are expressed on rat cutaneous keratinocytes, and
functional roles in the regulation of proliferation, differenti-
ation and cell death have been proposed [10]. In particular,
P2X5 receptors are expressed on cells undergoing pro-
liferation and differentiation, whereas P2X7 receptors are
associated with keratinised dead cells. P2Y2 receptors, found
in the basal layer of normal epidermis, are claimed to be
involved in keratinocyte proliferation [11]. P2Y1 receptors
are thought to be mitogenic in endothelial cells [4]. Previous
work on adult human interfollicular epidermis and primary
keratinocyte cultures has suggested that P2Y1 and P2Y2
receptors are involved in keratinocyte proliferation and that
P2X5 receptors are likely to be involved in keratinocyte
differentiation, whereas P2X7 receptors are likely to be part
of the machinery of end-stage terminal differentiation of
keratinocytes [12].
This study demonstrates for the first time the distribution
of P2X and P2Y receptors in human anagen hair follicles.
We propose that these receptors are part of the normal




Eight samples of normal hair-bearing human skin were
examined immunohistochemically in this study. Ethical
Committee approval was obtained to harvest human skin.
Samples of postoperatively redundant skin from otoplasty,
preauricular skin tags and from the leg were obtained. Tissue
was frozen in isopentane precooled in liquid nitrogen to
cryoprotect the tissue and prevent damage to the tissue
architecture from ice crystals. Blocks were sectioned at 10
µm on a cryostat (Reichert Jung CM1800), collected on
gelatine-coated slides and air-dried at room temperature. The
slides were stored at −20°C.
Antibodies
The immunogens used to produce polyclonal P2X5 and
P2X7 antibodies were synthetic peptides corresponding to
15 receptor-type-specific amino acids (AA) in the intracel-
lular C termini of the cloned rat and human P2X receptors,
as previously described [10, 13]. P2X5 and P2X7 antibodies
(provided by Roche Bioscience, Palo Alto, CA, USA)
were kept frozen at a stock concentration of 1 mg/ml.
Polyclonal anti-P2Y1 and P2Y2 antibodies were obtained
from Alomone Labs (Jerusalem, Israel) and corresponded
to the third extracellular loop of the P2Y1 (AA 242–258)
and P2Y2 receptor (AA 227–244). Antibodies were kept
frozen at a stock concentration of 0.6mg/ml (P2Y1, P2Y2).
Proliferating cell nuclear antigen (PCNA) is a marker for
proliferation in normal adult human keratinocytes [14].
Involucrin is a marker for keratinocyte differentiation [15].
PCNA (monoclonal antiproliferating cell nuclear antigen,
clone PC10, raised in mouse ascites fluid; Sigma Chemical
Co., Poole, UK) and involucrin (Sigma) antibodies were
raised in the mouse. Ki-67 antigen is a marker for cell pro-
liferation in normal human keratinocytes [16, 17]. Active
caspase-3 is part of the apoptotic machinery of the cell and is
expressed in terminally differentiating keratinocytes [18].
Ki-67 (DAKO, Heverlee, Denmark) and active caspase-3
(Abcam, Cambridge, UK) antibodies were both raised in the
rabbit.
Immunohistochemistry
For immunostaining of cryostat sections, the avidin-biotin
technique was used according to a revised protocol [19,
20]. Air-dried sections were fixed for 2 min in 4% form-
aldehyde in 0.1M phosphate buffer containing 0.2% of a
saturated solution of picric acid (pH 7.4). Fixation was
carried out at this point, as earlier fixation of the entire
tissue can result in alteration of the antibody binding sites,
interfering with staining. Endogenous peroxidase was
blocked for 10 min with 50% methanol containing 0.4%
hydrogen peroxide. Nonspecific binding sites were blocked
by a 20-min preincubation in 10% normal horse serum (NHS)
in 0.1 M phosphate buffer containing 0.05% merthiolate
(Sigma), followed by incubation with the primary antibodies
diluted to 1:100 or 1:200 in antibody diluent [10% NHS in
PBS + 2.5% sodium chloride (NaCl)] at 4°C overnight.
Subsequently, the sections were incubated with biotinylated
donkey anti-rabbit immunoglobulin G (IgG) (Jackson Immu-
noResearch Lab, West Grove, PA, USA) diluted to 1:500 in
1% NHS in PBS for 30 min, followed by ExtrAvidin
peroxidase conjugate (Sigma) diluted to 1:1000 in PBS for
30 min at room temperature. After a wash step, a nickel-
diaminobenzidine (DAB) enhancement technique was used to
visualise the reaction product. Sections were washed three
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times with PBS after each of the above steps except for after
preincubation with 10% NHS. After the last wash, sections
were dehydrated twice in isopropanol and mounted with
EUKITT (BDH Laboratory Supplies, Poole, UK). Control
experiments were carried out with primary antibodies omit-
ted from the staining procedure or the primary antibodies
preabsorbed with the corresponding peptides.
Double labelling of P2X or P2Y receptor antibodies
with either PCNA or involucrin
Sections were fixed and incubated with P2X or P2Y anti-
bodies overnight, as described above. After a wash step,
biotinylated donkey anti-rabbit IgG antibody, diluted 1:500
in 1% NHS in PBS, was then applied for 1 h, followed by
Streptavidin Texas red (Amersham Plc., Little Chalfont, UK),
diluted 1:200 in PBS-merthiolate for 1 h at room temperature.
Sections were preincubated for 30 min with 10% normal goat
serum (NGS) diluted in 0.1 M phosphate buffer containing
0.05% merthiolate (Sigma). They were then incubated for
2 h at room temperature with one of the following antibodies:
PCNA antibody (Sigma) diluted 1:1000; mouse monoclonal
anti-involucrin (Sigma) diluted 1:50. After a wash step, the
directly labelled secondary antibody goat anti-mouse FITC
(Nordic Immunological Laboratories, Tilburg, The Nether-
lands) was applied at a dilution of 1:200 for 1 h, and sections
were washed and mounted in Citifluor (Citifluor Ltd.,
Leicester, UK). P2X or P2Y receptor immunostaining ap-
peared red and PCNA and involucrin stained green.
Double-labelling of P2X or P2Y receptor antibodies
with either Ki-67 antigen or anti-human caspase-3
Sections were fixed and incubated with P2X or P2Y
antibodies overnight, as described above. After washing,
sections were incubated with biotinylated donkey anti-
rabbit IgG (Jackson) diluted to 1:500 in 1% NHS in PBS
for 1 h, followed by ExtrAvidin peroxidase conjugate (Sigma)
diluted to 1:1500 in PBS for 1 h, tyramide amplification
for 8 min (Tyramide Amplification Kit, NEN Life Science
Products, Boston, MA, USA) and then Streptavidin Texas red
(Amersham), diluted 1:200 in PBS-merthiolate for 10 min.
Sections were washed three times in PBS after each of the
above steps. Sections were preincubated for 20 min in 10%
NGS and incubated at room temperature for 2 h with one of
the following antibodies: rabbit anti-human Ki-67 antigen
(DAKO) 1:50 or rabbit anti-human active caspase-3 (Abcam).
Sections were washed and incubated with the directly labelled
secondary antibody Oregon-green-labelled goat anti-rabbit
IgG (Jackson) diluted 1:100 for 45 min. Sections were then
washed and mounted in Citifluor (Citifluor). P2X or P2Y
receptor immunostaining appeared red; Ki-67 and caspase-3
stained green.
Photography
The results were photographed using a Zeiss Axioplan
high-definition light microscope (Oberkochen, Germany)
mounted with a Leica DC 200 digital camera (Heerbrugg,
Switzerland).
Results
Only hair follicles in the anagen (growth) phase were
studied, as hair follicles in catagen (regression) or telogen
(resting) phases of the hair cycle were not seen in the
sections analysed.
P2X5, P2X7, P2Y1 and P2Y2 receptors are expressed
in human anagen hair follicles
P2X5 receptor immunoreactivity was observed in the hair
keratinocytes of all human skin samples. P2X5 receptor
staining was restricted to the medulla and both the IRS and
ORS (Fig. 1a,b), which were continuous with the surface
epidermis. P2X7 receptor immunostaining was present in
the stratum corneum of the overlying epidermis, but there
was no staining in the anagen hair follicle (Fig. 1c,d). P2Y1
receptors were found in the ORS and bulb of anagen hair
follicles but not in the IRS (Fig. 2a,b). P2Y2 receptors were
found in cells in the cortex, with possibly a few positive
cells at the edge of the medulla, but no staining in the
central medulla (Fig. 2c,d).
Double labelling of P2Y1 receptors with Ki-67 showed
that P2Y1 receptors were found in proliferating cells in the
ORS and bulb of anagen hair follicles (Fig. 3a,b). Double
labelling of P2Y2 receptors with PCNA showed that P2Y2
receptors were expressed in the cortex and possibly at the
edge of the medulla (Fig. 3c) and PCNA was expressed in
the ORS and bulb (Fig. 3c,d). P2Y2 receptors were only
expressed in viable cells and not in the keratinised hair
shaft or the central medulla (Fig. 3d). Involucrin was
expressed both in the cortex and IRS but not in the ORS
(Fig. 3e,f). P2X5 receptors were expressed in the medulla,
IRS and ORS. There was colocalisation of involucrin with
P2X5 receptor staining in the IRS and in a few cell layers at
the edge of the medulla (Fig. 3e,f). Double labelling of
P2X7 receptors with active caspase-3 did not show any
immunoreaction within the anagen hair follicle.
Control immunostaining experiments
Both omission of the primary antibody and preabsorption
with corresponding peptides were performed as controls.
The immunoreaction was abolished after preabsorption of
the P2X5 (Fig. 1e), P2X7 (Fig. 1f), P2Y1 (Fig. 2e) or P2Y2
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antibody (Fig. 2f) with the corresponding peptides, con-
firming the specificity of the immunoreaction.
Discussion
In this study, we have obtained using immunohistochemis-
try the first direct evidence for the expression of P2Y1,
P2Y2 and P2X5 receptors in human anagen hair follicles.
Double labelling of P2Y1 receptors with proliferation
markers Ki-67 and PCNA showed that P2Y1 receptors
were found in proliferating cells in the ORS and bulb in
anagen hair follicles. The ORS is established during the
early stages of anagen by the downwards migration of the
regenerating epithelium and then maintains itself (in
contrast to the IRS and hair shaft), independent of the
bulbar matrix, by basal cell growth [21]. Thickness and
cellularity of the ORS varies with the level of the follicle: it
is single-layered near the bulb, higher up it is composed of
multilayered cuboidal cells, and from the level of the
sebaceous gland upwards it becomes multilayered and is
structurally similar to the epidermis [22]. Previous work on
normal interfollicular epidermis has shown that P2Y1
receptors show a strong immunopositive signal in the basal
layer, and double labelling of P2Y1 receptors with
keratinocyte proliferation markers Ki-67 and PCNA in the
Fig. 1 Expression of P2X5 and
P2X7 receptors in human anagen
hair follicles. a Longitudinal
section of anagen hair follicle.
P2X5 receptor immunostaining
was present in the outer root
sheath (ORS) and medulla (M)
but not in the dermal papilla
(DP). Scale bar=75 μm. b
Transverse section of anagen
hair follicle. P2X5 receptor
immunostaining was present in
both the inner root sheath (IRS)
and the outer root sheath (ORS)
but not in the cortex (CTX) or in
the acellular medulla (M) of the
hair shaft at this level. Scale
bar=30 μm. c P2X7 receptor
immunostaining (arrow) was
present in the stratum corneum.
There was no immunoreaction
in the anagen hair follicle. Scale
bar=75 μm. d P2X7 receptor
immunostaining, transverse sec-
tion. There was no staining in
the outer root sheath (ORS),
cortex (CTX) or acellular me-
dulla (M) of the hair shaft at this
level. Scale bar=30 μm. e, f
Controls: the immunoreaction
was abolished after preabsorp-
tion of the e P2X5 and f P2X7
receptor antibodies with the
corresponding peptides, con-
firming the specificity of the
immunoreaction. Scale
bars=100 μm
334 Purinergic Signalling (2008) 4:331–338
interfollicular epidermis confirmed the presence of P2Y1
receptors in proliferating cells [12]. The P2Y1 receptor-
selective agonist 2-methylthio ADP caused an increase in
the number of human keratinocytes in vitro. It is therefore
consistent that P2Y1 receptors would have a proliferative
role in the anagen hair follicle ORS.
In anagen hair follicles, P2Y2 receptors were confined to
a spatially distinct group of cells in the cortex and at the
edge of the medulla, where there was no double labelling
with proliferation markers. Commitment to the formation of
the three hair shaft cell lineages (medulla, cortex, cuticle)
takes place in a subcompartment of the hair matrix known
as the precortex [1]. P2Y2 receptors seemed to be expressed
on early differentiated cells in the hair shaft, because they
were found on living cells of the cortex but not in the
differentiated hair cuticle. Previous work on normal inter-
follicular epidermis has shown that P2Y2 receptors are
expressed in all cells of the basal layer and in a few cells
within the stratum spinosum [12]. Stem cells in undamaged
epidermis divide infrequently, and it is the nonstem
daughters of stem cells, i.e. transit amplifying cells, which
are actively dividing [1]. Double labelling of P2Y2
receptors with keratinocyte proliferation markers Ki-67
and PCNA in the interfollicular epidermis confirmed the
presence of P2Y2 receptors in proliferating cells [12]. The
P2Y2 receptor agonist uridine 5’-triphosphate also caused
significant proliferation in keratinocytes [11, 12] and
HaCaT keratinocytes [23]. P2Y2 receptors stained all the
different cell populations within the basal layer of the
epidermis (i.e. stem cells, transit amplifying cells and
postmitotic cells). P2Y2 receptors may then cause prolifer-
ation in transit-amplifying cells in the epidermis. Although
Fig. 2 Expression of P2Y1 and
P2Y2 receptors in human anagen
hair follicles. a P2Y1 receptors
were found in the outer root
sheath (ORS) and bulb of ana-
gen hair follicles in longitudinal
section but not in the inner root
sheath (IRS). Scale bar=40 μm.
b In transverse section, P2Y1
receptors were only seen in the
outer root sheath (ORS). Scale
bar=40 μm. c P2Y2 receptors
were found in the cortex (CTX).
Scale bar=40 μm. d Transverse
section of anagen hair follicle:
P2Y2 receptors were seen in the
cortex (CTX) but not in the
central medulla (M), inner (IRS)
or outer root sheaths (ORS), or
in the surrounding adventitial
layer (A). Scale bar=40 μm. e, f
Controls: the immunoreaction
was abolished after preabsorp-
tion of the e P2Y1 and f P2Y2
receptor antibodies with the
corresponding peptides, con-
firming the specificity of the
immunoreaction. Scale
bars=100 μm
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Fig. 3 Double labelling of P2Y1 and P2Y2 receptors with markers for
cellular proliferation, and double labelling of P2X5 receptors with
markers for keratinocyte differentiation in anagen hair follicles. a
Double labelling of P2Y1 receptors (red) with Ki-67, a nuclear marker
for proliferating cells (green), to show that P2Y1 receptors are found
in proliferating basal cells in the outer root sheath (ORS) and bulb
region of the hair follicle in longitudinal section. Scale bar=50 μm. b
Transverse section: double labelling of P2Y1 receptors (red) with Ki-
67, a nuclear marker (green), to show that P2Y1 receptors are found in
proliferating cells in the outer root sheath (ORS) of the hair follicle.
Scale bar=50 μm. c Longitudinal section of anagen hair follicle
through the dermal papilla (DP): double labelling of P2Y2 receptors
(red) with proliferating cell nuclear antigen (PCNA), a marker for
proliferating cells (green), showed that P2Y2 receptors were found in
the cortex (CTX) and at the edge of the medulla (M) but not in the
central medulla. P2Y2 receptors were not found in the matrix (Ma),
where cells were positive for PCNA. Scale bar=75 μm. d
Longitudinal section of anagen hair follicle: P2Y2 receptors were
absent from the keratinised cuticle (Cu) of the hair shaft. PCNA was
also found in cells of the outer root sheath (ORS). Scale bar=75 μm. e
Double labelling of P2X5 receptors (red-brown) with involucrin, a
marker for differentiating cells (green). Involucrin was expressed both
in the inner root sheath (IRS), cortex (CTX) and in the outermost edge
of the medulla (M). P2X5 receptors were expressed in the inner (IRS)
and outer root sheaths (ORS) and in the medulla (M) and matrix cells
(Ma). There was yellow colocalisation with P2X5 receptors in the inner
root sheath and in cells at the outermost edge of the medulla (arrow).
The cortex only stained positive for involucrin, not P2X5 receptors. Scale
bar=50 μm. f Transverse section: double labelling of P2X5 receptors
(red) with involucrin (green). Involucrin was expressed in the inner root
sheath (IRS) and cortex (CTX) and colocalised (yellow) with P2X5
receptor staining in the inner root sheath (IRS). Scale bar=50 μm
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it is convenient to think of stem and transit-amplifying cells
as discrete populations from fully differentiated keratino-
cytes, there might be gradients of cell behaviour, ranging
from a cell that has maximum self-renewal and zero dif-
ferentiation capacity to one that has completed terminal
differentiation and cannot divide again. Transit-amplifying
cells would lie in the middle of each gradient [1]. In anagen
hair follicles, P2Y2 receptors are expressed on early dif-
ferentiated hair keratinocytes that contribute to the forma-
tion of the hair shaft. Cells positive for P2Y2 receptors in
hair follicles could still have some proliferative capacity
given the right stimulus.
In anagen hair follicles, P2X5 receptors were found on
cells in the IRS, ORS and medulla. P2X5 receptors are
expressed in the basal layer of the interfollicular epidermis
but are expressed more strongly in the stratum spinosum and
variably into the stratum granulosum [12]. The expression of
P2X5 receptors in the ORS was similar to that seen in
the epidermis, with basal cells labelling less strongly than
suprabasal cells. It has been proposed that P2X5 receptors
are involved in human epidermal keratinocyte differentia-
tion [10, 12]. There is evidence from other tissues regarding
the role of P2X5 receptors. In foetal rat skeletal muscle,
P2X5 receptors are sequentially expressed during develop-
ment [24] and associated with differentiating cells [25].
P2X5 receptors have also been implicated in the regulation
of osteoblastic differentiation and proliferation [26]. Invo-
lucrin is a marker of keratinocyte differentiation [27], which
is found in the epidermis in the upper stratum spinosum and
in the stratum granulosum. In the hair follicle, involucrin
is expressed in the hair cortex, medulla, IRS and the
innermost cells of the lower ORS [28]. Involucrin colo-
calised with P2X5 receptor staining in the IRS and in a
few cell layers at the edge of the medulla. This suggests a
role for P2X5 receptors in the differentiation of cells of the
medulla and IRS.
There was no staining with antibodies to P2X7 receptors
or active caspase-3 in the anagen hair follicle. Further work
on the expression of P2X7 receptors in different stages of
the hair cycle would be of interest. Periods of hair growth
(anagen) are followed by a regression phase (catagen), when
the lower part of the hair follicle undergoes programmed cell
death [2], and a resting phase (telogen), before onset of a
new growth phase. In this study, only hair follicles in the
anagen phase were studied, as hair follicles in catagen or
telogen phases of the hair cycle were not found in the
sections analysed. At any one time, 84% of scalp hairs are
in anagen, 2% in catagen and 14% in telogen [29]. The
P2X7 receptor is unlike other P2X receptors because it is a
bifunctional molecule that, in addition to forming a channel
permeable to small cations, can be triggered to form a
cytolytic pore permeable to large hydrophilic molecules up
to 900 daltons [30]. The opening of this pore results in the
increase in intracellular cytosolic free calcium ions and the
induction of cell death [31, 32]. P2X7 receptors are also
found on dendritic cells, macrophages and microglial cells,
where extracellular ATP can trigger apoptosis via these
receptors. There is increasing evidence that this process is
dependent on the caspase signalling cascade [33, 34]. It
would be of interest to see whether P2X7 receptors are
involved in the process of programmed cell death that occurs
during the catagen phase of the hair cycle.
In summary, P2 purinergic receptors are likely to be
involved in ORS cell proliferation via P2Y1 receptors found
in the bulb and ORS; IRS and medulla differentiation via
activation of P2X5 receptors; and early differentiation of
cells of the cortex and medulla of the hair shaft via activation
of P2Y2 receptors. Expression of P2 purinergic receptors in
the anagen hair follicle may have therapeutic implications
for treating hair loss. The expression of P2 receptors in
different cell lineages of the anagen hair follicle could
provide the prospect of engineering hair follicles in those
with hair loss or excess growth by using purinergic receptor
agonists and antagonists. Lack of growth reflects follicular
dynamics and represents the central mechanisms of most
common causes of alopecia. In androgenetic alopecia, the
hair-shaft diameter is reduced, and there is a progressive
decrease in anagen hair percentage, as well as a significant
reduction in proliferating cells [35]. The anagen phase is
also shorter [36]. This results in the formation of progres-
sively thinner and shorter hair. In some men, there is also
prolongation of the interval between shedding of the club
hair in telogen and the emergence of a replacement hair in
the anagen phase, giving rise to an increase in the number
of “empty” follicles [37]. Functional work on hair-follicle
cycling, cell proliferation and differentiation using puriner-
gic receptor agonists and antagonists may lead to new
approaches in the treatment of hair loss.
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